Statins & Stroke: Lowering Risk After a Bleed?
- People who have experienced a brain bleed, also known as intracerebral hemorrhage, may face a reduced risk of subsequent stroke, notably ischemic stroke, if they take cholesterol-lowering drugs,...
- Ischemic stroke, the moast common type, occurs when blood flow to the brain is blocked.
- David Gaist, MD, PhD, of the University of Southern Denmark, noted previous research yielded conflicting results regarding stroke risk and statin use after a bleeding stroke.
Exploring the link between statins and lowered stroke risk after brain bleeds, this report unveils critical findings. Recent research suggests that statins could be beneficial in reducing the risk of ischemic stroke, the most common type of stroke, following an initial brain bleed, or intracerebral hemorrhage.This compelling study, drawn from Danish health records of over 15,000 individuals, analyzed statin use and subsequent stroke occurrences. The analysis indicates a potential for statins to decrease the chance of additional strokes by 12%,and specifically,a 21% reduction in the risk of ischemic stroke. This study offers critically important insights that news Directory 3 is bringing to light. However,the study found no correlation between statin use and recurrent bleeding strokes. Curious about the nuances? Discover what’s next in stroke prevention strategies.
Statins linked to Lower stroke Risk after Brain Bleeds
Updated June 28, 2025
People who have experienced a brain bleed, also known as intracerebral hemorrhage, may face a reduced risk of subsequent stroke, notably ischemic stroke, if they take cholesterol-lowering drugs, or statins. Teh findings come from a study analyzing Danish health records.
Ischemic stroke, the moast common type, occurs when blood flow to the brain is blocked. Intracerebral hemorrhage involves bleeding within the brain tissue.
David Gaist, MD, PhD, of the University of Southern Denmark, noted previous research yielded conflicting results regarding stroke risk and statin use after a bleeding stroke. The study,thus,aimed to further evaluate whether statin use after such a stroke correlated with the risk of additional strokes,both those caused by bleeding and blood clots.
The research team reviewed health records in Denmark, identifying 15,151 individuals who had experienced a first bleeding stroke. Participants were monitored for an average of 3.3 years, starting 30 days after their initial stroke, until they experienced another stroke, death, or the study’s conclusion. Prescription data provided information on statin use.
The researchers compared 1,959 individuals who had another stroke with 7,400 who did not, matching them by age, sex, and other relevant factors. Among those who had a subsequent stroke, 39% were taking statins, compared to 41% of those who did not have another stroke.
After accounting for factors such as high blood pressure,diabetes,and alcohol consumption,statin use correlated with a 12% decrease in the risk of another stroke. Further analysis revealed statin use was associated with a 21% lower risk of ischemic stroke following the initial bleeding stroke.
Though,the study found no connection between statin use and the recurrence of bleeding stroke. Researchers compared 984 individuals who had another bleeding stroke to 3,755 who did not, and after adjustments, no statistically important link emerged.
Gaist said the findings offer reassurance for individuals taking statins after experiencing a bleeding stroke. He cautioned, however, that the reduced risk primarily applied to ischemic stroke, and further research is necessary to validate these results.
One limitation of the study is its focus on a Danish population,primarily of European ancestry,which may limit the generalizability of the findings to other populations. The Novo Nordisk Foundation provided support for the study.